TPO-RAs, like eltrombopag, romiplostim, and, more recently, avatrombopag, are indicated to restore platelet counts in ITP and severe aplastic anemia [16] and have also been successfully used after allogeneic stem cell transplantation or chemotherapy [29,30]. This evidence concerns the gene TPO and aplastic anemia.